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TRIF-related adaptor molecule (TRAM) (Yamamoto etBC Cancer Agency
al., 2003b), and perhaps other TIR-containing proteins601 West 10th Avenue
(O’Neill et al., 2003). The death domain-containingVancouver, British Columbia, V5Z 1L3
MyD88, together with TIRAP, then recruits, via homophi-Canada
lic interactions, the death domain-containing serine/
threonine kinases, IL-1R-associated kinase (IRAK)-1
(aka IRAK) (Medzhitov et al., 1998) and/or IRAK-4 (Fitz-Summary
gerald et al., 2001; Li et al., 2002), as well as the two
kinase-inactive, negative regulators, IRAK-2 (Muzio etAn initial exposure to lipopolysaccharide (LPS) in-
al., 1997) and IRAK-M (Kobayashi et al., 2002; Suzuki etduces a transient state of hyporesponsiveness to a
al., 2002). IRAK-1 and IRAK-4 then autophosphorylate,subsequent challenge with LPS. The mechanism un-
dissociate from the TLR4 complex, and bind/activatederlying this phenomenon, termed endotoxin toler-
tumor necrosis factor receptor-activated factor 6 (TRAF6)ance, remains poorly understood despite a recent re-
to initiate signaling cascades that lead to p38, Erk,surgence of interest in this area. We demonstrate
c-Jun, AP1, and NFB activation and subsequent proin-herein that SHIP/ bone marrow-derived macro-
flammatory cytokine synthesis (Masuda et al., 2002;phages (BMmφs) and mast cells (BMMCs) do not dis-
Neumann et al., 2002). In addition to this MyD88-depen-play endotoxin tolerance. Moreover, an initial LPS
dent pathway, TLR4 recruits TICAM-1 in a MyD88-inde-treatment of wild-type BMmφs or BMMCs increases
pendent manner (Hoebe et al., 2003; Yamamoto et al.,the level of SHIP, but not SHIP2 or PTEN, and this
2003a). TICAM-1 then, via two protein kinases (TBK-1increase is critical for the hyporesponsiveness to sub-
and IKK [Fitzgerald et al., 2003]), activates NFB andsequent LPS stimulation. Interestingly, this increase
AP1 (albeit with slower kinetics than the MyD88-depen-in SHIP protein is mediated by the LPS-induced pro-
dent pathway) and upregulates IFN via the transcrip-duction of autocrine-acting TGF and neutralizing an-
tion factor IRF3. IFN in turn acts in an autocrine fashiontibodies to TGF block LPS-induced endotoxin toler-
through its cell surface receptor to activate the Jak/ance. In vivo studies with SHIP/ and SHIP/ mice
STAT1 pathway and trigger the transcription of inducibleconfirm these in vitro findings and show a correlation
nitric oxide synthase (iNOS) and NO production (Imlerbetween the duration of endotoxin tolerance and ele-
and Hoffmann, 2003).vated SHIP levels.
Although these LPS-induced proinflammatory mole-
cules are indispensable for counteracting the growthIntroduction
and dissemination of gram-negative bacteria, overpro-
duction can lead to sepsis syndrome, aka endotoxinLipopolysaccharide (LPS), also known as endotoxin, is
shock. This is characterized by fever, myocardial dys-a potent inducer of inflammation that acts by stimulating
function, acute respiratory failure, hypotension, multipleimmune system cells to produce proinflammatory cyto-
organ failure, and in a large number of cases, deathkines, proteases, eicosinoids, and reactive oxygen and
(West and Heagy, 2002). Interestingly, however, a priornitrogen species (West and Heagy, 2002). It does so by
exposure to a low level of LPS induces a transient state
binding to a soluble LPS binding protein (LBP), and
of cell refractoriness to subsequent LPS exposure, a
this LPS/LBP complex binds the glycosyl-phosphatidyl
phenomenon known as “endotoxin tolerance” (West and
inositol (GPI)-linked CD14 on the surface of macro- Heagy, 2002). Induction of tolerance is thought to pro-
phages, monocytes, neutrophils, lymphocytes, and tect the host from cellular damage caused by hyperacti-
mast cells (Ulevitch and Tobias, 1995). CD14 then pre- vation of macrophages and other immune cells and likely
sents the LPS/LBP complex to the MD-2/Toll-like recep- represents a means of immune cell adaptation to a per-
tor 4 (TLR4) complex (da Silva Correia et al., 2001; Lien sistent bacterial infection. While many investigators are
et al., 2000; Poltorak et al., 1998, 2000), and this triggers actively studying this phenomenon, the mechanism(s)
the dimerization of TLR4. Like the other ten TLRs (Akira underlying endotoxin tolerance has not been fully eluci-
et al., 2001; Zhang et al., 2004) and the interleukin-1 dated. What is known is that in endotoxin tolerized my-
receptor (IL-1R), the cytoplasmic tail of TLR4 contains eloid cells, restimulation with LPS results in reduced
a Toll-IL-1R (TIR) domain (Imler and Hoffmann, 2003). MyD88 recruitment to TLR4, MyD88/IRAK association,
Upon TIR-mediated TLR4 dimerization, this TIR domain IRAK kinase activation and expression (Yeo et al.,
recruits, via homophilic interactions, several TIR-con- 2003), and p38 phosphorylation and NFB activation
taining intracellular adaptor proteins, including MyD88 (Medvedev et al., 2000; O’Neill et al., 2003; West and
(Akira et al., 2001; Medzhitov et al., 1998), Toll receptor Heagy, 2002). As a result, tolerized cells produce less
IL-1R domain-containing adaptor protein (TIRAP) (aka proinflammatory cytokines and NO in response to a sec-
MyD88-adaptor-like [Mal]; Fitzgerald et al., 2001; Horng ond dose of LPS. However, endotoxin tolerance is not
synonymous with a “global shutdown” of LPS-induced
events since normal or elevated levels of antiinflamma-*Correspondence: gkrystal@bccrc.ca
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Figure 1. SHIP/ Mice and BMmφs Are Hyperresponsive to LPS
(A) 5-week-old SHIP/ (open circles) and SHIP/ (closed square) littermates (n  5 for each) were injected i.p. with 40 mg/kg LPS and
lethality observed over 60 hr. Data are representative of two independent experiments.
(B and C) SHIP/ (white bars) and SHIP/ (black bars) BMmφs at 1  106 cells/ml were (B) incubated 100 ng/ml LPS for 3 hr and the
culture supernatants assessed for TNF	, IL-6, and IL-1 levels by ELISA or (C) incubated100 ng/ml LPS for 48 hr and the culture supernatants
assessed for NO levels.
(D) SHIP/ (white bars) and SHIP/ (black bars) BMmφs were stimulated LPS as above 15 
M LY294002 (LY) or 50 nM wortmannin (W)
and the levels of TNF	, IL-6, and IL-1 measured. Results shown are the mean  SEM of six determinations. *p  0.05.
tory genes, including IL-10, IL-1R antagonist, TNFRII, type littermates died within 50 hr of being injected. We
then asked if there were any differences in the LPS-and SOCS1 are produced by tolerized cells (Kinjyo et
al., 2002; Nakagawa et al., 2002; West and Heagy, 2002). induced production of proinflammatory cytokines and
NO from “naive” primary, bone marrow-derived macro-We recently reported that in IgE  antigen stimulated
bone marrow-derived mast cells (BMMCs), the SH2- phages (BMmφs) and BMMCs from SHIP/ and
SHIP/ mice. Specifically, we stimulated SHIP/ andcontaining inositol phosphatase, SHIP, acts as a potent
endogenous inhibitor of the NFB pathway (Kalesnikoff SHIP/ BMmφs and BMMCs with 100 ng/ml of LPS for
3 hr and measured the levels of TNF	, IL-6, and IL-1et al., 2002). SHIP is thought to exert this inhibitory effect
primarily through the hydrolysis of the phosphatidylino- in the medium (Figure 1B) or 48 hr and measured the
level of NO in the medium (Figure 1C). As shown insitol 3-kinase (PI3K)-generated second messenger PI-
3,4,5-P3 to PI-3,4-P2 (Huber et al., 1998). Since endotoxin Figure 1, the levels of both the cytokines and NO
were significantly elevated in LPS-stimulated SHIP/tolerance is characterized by reduced NFB activation,
we asked if SHIP could be involved in this phenomenon. BMmφs (and in LPS-stimulated SHIP/ BMMCs, Sup-
plemental Figures S1A and S1B). Furthermore, the LPS-
induced production of proinflammatory cytokines byResults
BMmφs was inhibited by the PI3K inhibitors LY294002
and wortmannin (Figure 1D). Similar results were ob-SHIP/ Mice, Bone Marrow-Derived Macrophages,
and Mast Cells Are Hyperresponsive to LPS tained with BMMCs (Supplemental Figure S1C).
Before investigating the role of SHIP in endotoxin toler-
ance, we asked whether SHIP/ mice were more sus- SHIP/ Macrophages and Mast Cells
Do Not Display Endotoxin Toleranceceptible to LPS-induced toxicity. For these studies,
5-week-old SHIP/ and SHIP/ mice were injected in- Having established that SHIP negatively regulates LPS-
induced proinflammatory cytokine and NO productiontraperitoneally (i.p.) with 40 mg/kg of LPS. As shown in
Figure 1A, all of the SHIP/ mice but none of the wild- in wild-type BMmφs and BMMCs, we next investigated
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the role that SHIP plays in the regulation of endotoxin A Second Exposure to LPS Leads to a Reduced
Phosphorylation of Stat1, Akt, and Erk1/2tolerance. Specifically, we treated SHIP/ and SHIP/
in SHIP/, but Not in SHIP/, MacrophagesBMmφs and BMMCs 100 ng/ml LPS for 24 hr and
Because of the inherent limitations of enhanced chemo-then washed and stimulated the cells 100 ng/ml LPS.
luminescence (ECL) to quantitate protein levels in West-As shown in the left panels of Figures 2A and 2B, SHIP/
ern blots, we switched to the Odyssey infrared imagingBMmφs pretreated with LPS for 24 hr became tolerant
system to monitor changes in SHIP protein (and SHIPto a second dose of LPS; i.e., their production of TNF	,
phosphorylation) after LPS stimulation. Specifically,IL-6, IL-1, and NO was totally abrogated. In contrast,
SHIP/ and SHIP/ BMmφs were stimulated with 100SHIP/ BMmφs were unaffected by the precondi-
ng/ml LPS. At 8 hr the cells were washed free of LPStioning regimen of LPS (right panels of Figures 2A and
(to allow signaling to return to baseline) and at 24 hr2B), and the second response to LPS was as robust as
restimulated with a second dose of 100 ng/ml LPS. Asthe first. The same trend was observed with BMMCs
shown in the top-left blot of Figure 3E, a substantial(Supplemental Figures S2A and S2B). We then tested
increase in SHIP protein was first observed in responsedifferent preconditioning (tolerizing) doses of LPS to
to LPS between 6–9 hr, reaching peak levels at 25 hrsee their effects on subsequent LPS-induced cytokine
(approximately 9-fold, by IR spectroscopy) and re-production. As shown in Figure 2C, a tolerizing dose of
mained at plateau levels for at least 30 hr after the initial10 or 100 ng/ml LPS resulted in an inhibition of TNF	
exposure to LPS. Interestingly, tyrosine phosphorylation
and IL-6 production in response to a second challenge
at the second NPXY site within SHIP was first apparent
dose of either 10 or 100 ng/ml LPS in SHIP/ BMmφs.
at 30 min and peaked at 6 hr (second left blot, Figure
Also, as expected (Kobayashi et al., 2002), we found that 3E). Although a second exposure to LPS resulted in
the higher the tolerizing dose, the poorer the response phosphorylation of SHIP as well, it was weaker than that
to the second dose in wild-type BMmφs. In contrast, elicited by the first exposure, especially given the higher
regardless of the tolerizing dose used, there was no level of SHIP protein at these later time points.
reduction in cytokine production in response to the sec- We then compared various signaling events elicited by
ond dose of LPS in SHIP/ BMmφs. We also carried LPS in SHIP/ and SHIP/ BMmφs by using identical
out these studies with SHIP/ and SHIP/ peritoneal amounts of cell lysates and ECL exposure times (Figure
macrophages and obtained similar results (Supplemen- 3E, blots 3–6 [read top to bottom]). A comparison of
tal Figure S2C). the left and right third blots revealed that the tyrosine
phosphorylation of Stat1 was substantially stronger in
SHIP/ BMmφs, as expected, given the literature sug-
LPS Induces an Increase in SHIP Protein gesting that the PI3K pathway is a positive regulator of
in Wild-Type Macrophages and Mast Cells this pathway (Rhee et al., 2003; Weinstein et al., 2000).
To determine at what level SHIP was acting to induce As well, the LPS-induced, PI3K-mediated elevations in
endotoxin tolerance, we asked if SHIP was required to PI-3,4,5-P3, assessed by measuring phosphoSer473-Akt
downregulate the cell surface expression of TLR4, since levels (Medvedev et al., 2000; Scheid et al., 2002), were
such a reduction has been proposed as a mechanism markedly higher in the SHIP/ macrophages (as ex-
pected from our previous studies with SHIP/ andfor inducing endotoxin tolerance (Sato et al., 2000). By
SHIP/ BMMCs [Scheid et al., 2002] [blot 5]). In addi-using flow cytometry, we measured TLR4 surface ex-
tion, the LPS-induced phosphorylation of Erk1/2 waspression on SHIP/ and SHIP/ BMmφs and BMMCs
substantially higher in the SHIP/ cells (blot 6). More(Supplemental Figure S3) at different times after expo-
importantly, as can be seen in blots 3, 5, and 6 (and in thesure to LPS and found no detectable difference in TLR4
longer exposures of the Akt and Erk1/2 phosphorylationlevels between SHIP/ and SHIP/ cells at any of the
patterns in the SHIP/ cells (the two bottom-left blots),times examined.
a second LPS stimulation of SHIP/ BMmφs yieldedWe then examined SHIP protein levels after an initial
far less phosphorylation of Stat1, Akt, and Erk1/2 phos-LPS treatment, since it had been reported that exposure
phorylation than the first LPS stimulation. This was notof resting B cells to LPS for 48 hr increased the levels
the case, however, with SHIP/ BMmφs, where theof both SHIP and SHIP2 (Brauweiler et al., 2001). Specifi-
second exposure to LPS resulted in a similar phosphory-cally, SHIP/ BMmφs were LPS treated for different
lation of these signaling intermediates as the first (righttimes (Figure 3A) and with various concentrations of
blots 3, 5, and 6). Of note, there is a nice inverse correla-
LPS (Figure 3B). These experiments revealed that 10–
tion between SHIP levels and Akt phosphorylation. Inter-
100 ng/ml of LPS induced a dramatic increase in SHIP estingly, differences in the LPS-induced phosphoryla-
protein by 24 hr (5-fold by densitometry), and it remained tion of the p65 subunit of NFB in SHIP/ and SHIP/
above control levels for at least 48 hr (Figure 3A, top). BMmφs were more subtle (blot 3). Whether assessed
Furthermore, this increase in SHIP protein was detect- by using the phospho-p65(Ser536) shown in Figure 3 or
able in BMmφs treated with as little as 1 ng/ml of LPS phospho-p65(Ser276) (data not shown), they appeared
for 24 hr (2-fold by densitometry, Figure 3B, top). Similar slightly higher at early times in the SHIP/ cells,
results were obtained with BMMCs (Figures 3C and 3D). dropped after 16 hr, and then increased in response to
Interestingly, no significant changes in SHIP2 or PTEN a second LPS stimulation. In contrast, in the SHIP/
levels were detectable in either cell type (Figures 3A and BMmφs the levels were higher at later times (after 16
3C), revealing that of the three PI-3,4,5-P3 phospha- hr), remained high, and were not influenced by a second
tases, only SHIP increases dramatically in response to exposure to LPS. Failure to induce p65 phosphorylation
by the tolerized SHIP/ BMmφs coupled with their re-LPS in BMmφs and BMMCs.
Immunity
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Figure 2. SHIP/ Macrophages Do Not Dis-
play Endotoxin Tolerance
SHIP/ (left) or SHIP/ (right) BMmφs were
untreated (white bars) or tolerized (black bars)
with 100 ng/ml LPS for 24 hr and then chal-
lenged (LPS) or not () with 100 ng/ml LPS.
(A) After 3 hr of incubation the media were
assessed for TNF	, IL-6, and IL-1 levels. (B)
After 48 hr of incubation the media were as-
sessed for NO levels. Results shown for (A)
and (B) are the mean SEM of six determina-
tions. *p  0.01; N.S., not significantly differ-
ent. (C) SHIP/ (left) and SHIP/ (right)
BMmφs (0.5 106 cells/ml) were tolerized for
24 hr and then challenged with the indicated
doses of LPS. After 3 hr of incubation the
media were assessed for TNF	 (top panels)
and IL-6 (bottom panels) levels. Results
shown are the mean SEM of six determina-
tions.
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Figure 3. LPS Induces an Increase in SHIP Protein in Wild-Type Macrophages and Mast Cells, and SHIP Blocks the Phosphorylation of Stat1,
Akt, and Erk1/2 in Response to a Second LPS Exposure
SHIP/ BMmφs (A) or BMMCs (C) were treated without (C) or with 100 ng/ml LPS for the indicated times and whole-cell lysates subjected
to Western analysis with anti-SHIP, anti-SHIP2, or anti-PTEN (top three blots in both [A] and [C]). BMmφs (B) or BMMCs (D) were treated
with the indicated concentrations of LPS for 24 hr and subjected to Western analysis with anti-SHIP (top blots). (E) SHIP/ and SHIP/
BMmφs were starved overnight in IMDM  5% FCS and then treated with 100 ng/ml LPS for the indicated times. At 8 hr, the cells were
washed free of LPS and at 24 hr subjected to a second 100 ng/ml LPS for the indicated times. The cells were boiled in SDS-sample buffer
and whole-cell lysates subjected to Western analysis with the indicated antibodies. The top two blots (both left and right) were analyzed with
an Odyssey infrared imaging system. The third through seventh blots were ECL Western blots exposed for 15 s, while the bottom two blots
on the left were exposed for 1 min. All blots were reprobed with anti-GAPDH to show equal loading. All results are representative of three
separate experiments.
duced Stat1 phosphorylation are likely critical to their BMmφs (Figure 4A, left) or BMMCs (Figure 4A, right),
they completely blocked the LPS-induced increase ininability to produce proinflammatory cytokines in re-
sponse to a second challenge with LPS SHIP protein. As shown in Figure 4A, a control oligonu-
cleotide (S) had no effect. We then assessed the effect
of these SHIP antisense oligonucleotides (AS1  AS2)SHIP Antisense Oligonucleotides Block Endotoxin
Tolerance in Macrophages and Mast Cells on endotoxin tolerance. Specifically, we examined the
ability of a second dose of LPS to induce proinflamma-To ensure that our inability to tolerize SHIP/ BMmφs
and BMMCs was due to the absence of SHIP and not tory cytokine and NO production when these oligonucle-
otides were added together with the first dose of LPS,to secondary changes within these cells, we utilized
SHIP antisense oligonucleotides (AS1 and AS2) to re- 24 hr earlier. As shown in Figure 4B, addition of AS1 
AS2, but not S, blocked the reduction in TNF	, IL-6,duce SHIP expression in SHIP/ cells. Preliminary stud-
ies revealed that we could not reduce SHIP protein levels and IL-1 production in both SHIP/ BMmφs (left) and
BMMCs (right). This also held true for NO productionin non-LPS-treated BMmφs or BMMCs after 48 hr with
these two SHIP antisense oligonucleotides (data not in both SHIP/ BMmφs (Figure 4C, left) and BMMCs
(Figure 4C, right). These studies revealed that the in-shown), consistent with SHIP being a long-lived protein
(Damen et al., 1998). However, when these oligonucleo- crease in SHIP levels by the tolerizing dose of LPS was
required for endotoxin tolerance.tides were added at the same time as LPS to SHIP/
Immunity
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Figure 4. SHIP Antisense Oligonucleotides
Block LPS-Induced Endotoxin Tolerance in
Wild-Type Macrophages and Mast Cells
(A) SHIP/ BMmφs (left) or BMMCs (right)
at 106 cells in 0.1 ml were untreated (C) or
treated with LPS for 24 hr in the absence (C)
or presence of 5 
M AS1 or AS2 or 2.5 
M
AS1 2.5
M AS2 or 5
M control (S) oligonu-
cleotide and subjected to Western analysis
by using anti-SHIP and reprobed with anti-
Shc to show equal loading. Results are repre-
sentative of three separate experiments.
(B and C) BMmφs (left) or BMMCs (right) at
106 cells in 0.1 ml, tolerized for 24 hr with 100
ng/ml LPS (black bars) or not (white bars) in
the absence () or presence of 2.5 
M AS1
2.5 
M AS2 (AS) or 5 
M S oligonucleotides
were challenged with 100 ng/ml LPS. The cul-
ture supernatants were then assessed for (B)
TNF	, IL-6, or IL-1 after 3 hr of incubation
and (C) NO levels after 48 hr of incubation.
Results shown in (B) and (C) are the mean 
SEM of six determinations. *p  0.02; N.S.,
not significantly different.
The LPS-Induced Increase in SHIP Is Mediated ated by an autocrine production of TGF. To test this,
we first asked if TGF could increase SHIP levels inby Autocrine-Acting TGF
It was recently reported that TGF, via a SMAD-depen- SHIP/ BMmφs and BMMCs. As shown in Figure 5A,
this was indeed the case, and the TGF-induced in-dent pathway, is a potent inducer of SHIP expression
in monocytes/macrophages (Valderrama-Carvajal et al., crease in SHIP was more rapid (peaking by 8 hr) than
that invoked by LPS (see Figure 3E). Importantly, we2002). We therefore asked if the LPS-induced increase
in SHIP levels in BMmφs and BMMCs might be medi- also found that LPS could induce the secretion of TGF
SHIP Is Essential for Endotoxin Tolerance
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Figure 5. LPS-Induced TGF Production In-
creases SHIP Levels
(A) SHIP/ BMmφs (left) or BMMCs (right)
were untreated (“C” and “0,” respectively) or
treated with 20 ng/ml TGF for the indicated
times and cell lysates subjected to Western
analysis with anti-SHIP. The blots were re-
probed with anti-Shc to show equal loading.
Results are representative of three separate
experiments.
(B) SHIP/ (white bars) and SHIP/ (black
bars) BMmφs (left) or BMMCs (right) were
treated 100 ng/ml LPS for 24 hr, and serum-
free culture supernatants assessed for TGF
levels by ELISA. Results shown are the
mean SEM of six determinations. *p  0.01
compared to untreated cells.
(C) SHIP/ BMmφs (left) or BMMCs (right)
were untreated (C) or treated with 100 ng/ml
LPS for 24 hr in the absence (C) or presence
of anti-TGF blocking antibody (	TGF) or
irrelevant isotype control antibody (irrel) and
whole-cell lysates subjected to Western anal-
ysis with anti-SHIP. The blots were reprobed
with anti-Shc to show equal loading. Results
are representative of three experiments.
(D) SHIP/ BMmφs (left) or BMMCs (right)
were untreated (white bars) or tolerized (black
bars) with 100 ng/ml LPS for 24 hr  	TGF
or irrel antibody and then 100 ng/ml LPS
for 48 hr and the NO levels assessed (top) or
3 hr and the TNF	 levels assessed (bottom)
in the supernatants. Results shown are the
mean SEM of six determinations. *p 0.02;
N.S., not significantly different.
(E) SHIP/ BMmφs were treated with 100
ng/ml LPS for the indicated times and the
levels of SHIP, SOCS1, and IRAK-M mRNA
determined by RT-PCR. -actin mRNA levels
were assessed as a control for mRNA levels.
Negative controls were minus reverse tran-
scriptase and minus template. Results are
representative of three experiments.
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from SHIP/ and SHIP/ BMmφs and BMMCs (Figure neal cavity. As shown in Figure 6A, SHIP/mice showed
increased MPO activity in response to a challenge dose5B) at levels that were in the range of TGF concentra-
of LPS (lane 2), but not, as expected, if they were pre-tions, causing increased SHIP levels (ie, 0.1 to 1 ng/ml).
viously tolerized with a low dose of LPS (lane 4). SHIP/We then treated SHIP/ BMmφs and BMMCs with LPS
mice, on the other hand, had a higher baseline MPOfor 24 hr  a neutralizing anti-TGF antibody and moni-
activity (lane 5) that increased dramatically upon chal-tored the increase in SHIP by Western analysis. As
lenge with LPS (lane 6). More importantly, 27 hr after ashown in Figure 5C, neutralizing anti-TGF, but not an
tolerizing dose, the MPO activity (lane 7) was similarirrelevant antibody, completely abrogated the LPS-
to that seen in untreated mice (lane 5), but, upon LPSinduced increase in SHIP in both cell types. This strongly
challenge, the level of MPO activity (lane 8) was at leastsuggested that the LPS-induced increase in SHIP was
as high as that seen in nontolerized, LPS-challengedmediated by the autocrine action of TGF. We then
mice (lane 6). This suggested that the LPS-induced im-asked if anti-TGF antibodies could also prevent the
mune cell recruitment into the peritoneal cavity ofinduction of endotoxin tolerance. Specifically, neutraliz-
SHIP/ mice was not diminished by a previous toleriz-ing anti-TGF antibodies were given at the same time
ing dose of LPS.as the first dose of LPS and this enabled the second
We also assayed the TNF	 and IL-6 levels in the perito-dose of LPS, given 24 hr later, to stimulate a similar
neal lavage fluid (Figure 6B) and plasma (Figure 6C) fromproduction of TNF	 and NO as that elicited by the first
these mice. For SHIP/ mice, the levels of these twodose from SHIP/ BMmφs (Figure 5D, left) and BMMCs
cytokines were elevated after challenge (lane 2), but if(Figure 5D, right).
these mice were first tolerized with a low dose of LPS,
the subsequent production of these two cytokines in
response to a challenge dose was below the limits ofThe LPS-Induced Increase in SOCS1 and IRAK-M
detection (lane 4). For SHIP/ mice, on the other hand,mRNA Precedes that of SHIP
an initial “tolerizing” dose did not lower the levels ofIt was recently reported that LPS upregulates the mRNA
these two cytokines when assessed 3 hr after a chal-and protein levels of the negative regulator IRAK-M in
lenge dose (compare lanes 6 and 8). Hence, in vivo,BMmφs and that this increase plays a role in mediating
SHIP/ mice do not become tolerant to LPS, reflectingendotoxin tolerance in these cells (Kobayashi et al.,
our in vitro findings.
2002). Moreover, several reports have suggested that
Lastly, since endotoxin tolerance has been reported
LPS induces an increase in the cytokine signaling sup-
to last approximately 1–3 weeks after a tolerizing dose
pressor SOCS1 and that this may play an important role
of LPS (West and Heagy, 2002), we asked if the elevated
in endotoxin tolerance as well (Crespo et al., 2000; Kinjyo SHIP levels correlated with this duration. To test this,
et al., 2002; Nakagawa et al., 2002). To gain some insight we i.p. injected mice with a tolerizing dose of LPS or
into the relative kinetics of induction of IRAK-M, SOCS1, not (day 0) and then harvested the peritoneal macro-
and SHIP, we treated SHIP/ BMmφs with LPS and phages 1, 2, 4, and 7 days later. As shown in Figure 6D,
examined their mRNA levels by RT-PCR. As shown in the levels of SHIP protein remained elevated for this
Figure 5E, we found that SOCS1 showed the most rapid entire period. A reblot with anti-Shc antibodies estab-
induction (peaking at 3 hr) in response to LPS in SHIP/ lished equal loading. We repeated this experiment, this
BMmφs, IRAK-M gave an intermediate rate of induction time collecting both peritoneal macrophages and the
(peaking at 6 hr), and SHIP showed the slowest induc- cell-free lavage fluid (for cytokine determination) from
tion. These kinetics for IRAK-M and SOCS1 are in keep- mice challenged for 3 hr with LPS after tolerizing for 0,
ing with published findings (Crespo et al., 2000; Koba- 7, and 18 days. We found that SHIP levels were almost
yashi et al., 2002), and the SHIP induction is consistent back to non-LPS-injected levels by 18 days (Figure 6E).
with our SHIP protein results (Figure 3E). Of interest, The challenge dose of LPS was given 3 hr prior to harvest
SOCS1 mRNA levels dropped markedly after peaking to determine if tolerance was still present and, as shown
at 3 hr, while SHIP mRNA levels consistently showed a in Figure 6F, the levels of TNF	 and IL-6 in the peritoneal
transient drop 3–6 hr after LPS and then remained high lavage fluids showed a nice inverse correlation with the
after 12 hr. levels of SHIP protein.
Discussion
Endotoxin Tolerance Does Not Occur
in SHIP/ Mice In this study we have explored SHIP’s role in endotoxin
To determine whether SHIP was required for endotoxin tolerance by using both primary macrophages, which
tolerance in vivo, SHIP/ and SHIP/ mice were toler- are a major source of proinflammatory cytokines in the
ized or not with an i.p. injection of a low dose (1 mg/kg) body in response to LPS (Shnyra et al., 1998), and pri-
of LPS. The mice were then challenged or not 24 hr later mary mast cells, which also have been shown recently
with a high dose of LPS (10 mg/kg) i.p. Three hours after to play an important role in producing proinflammatory
the challenge dose, the mice were sacrificed and the cytokines and recruiting neutrophils in vivo in response
myeloperoxidase activity of cells in the peritoneal lavage to LPS (Malaviya and Georges, 2002; Supajatura et al.,
fluids measured to assess neutrophil influx into the peri- 2002). Taken together, our data suggest a model (see
toneal cavity. Myeloperoxidase activity is expressed by Figure 7) in which an initial exposure to LPS activates
neutrophils and immature monocytes and so does not a number of intracellular signaling pathways that lead
to the production of TNF	, IL-6, IL-1, and NO. Onedistinguish the specific cell type recruited into the perito-
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Figure 6. SHIP Is Required In Vivo for LPS-
Induced Endotoxin Tolerance
SHIP/ (open squares) and SHIP/ mice
(closed circles) were treated i.p. injection
with 1 mg/kg LPS (). After 24 hr, mice were
either not challenged () or challenged by i.p.
injection with 10 mg/kg LPS (). 3 hr after the
challenge, mice were sacrificed and perito-
neal lavage fluids collected to (A) isolate the
cells for their myeloperoxidase (MPO) activity
and (B) use the lavage fluid supernatants to
assess TNF	 (left) and IL-6 (right) levels by
ELISA. (C) Cardiac puncture was performed
to measure plasma levels of TNF	 and IL-6.
(D and E) SHIP/ mice were tolerized by i.p.
injection with 1 mg/kg LPS. Three mice were
(D) sacrificed 0, 1, 2, 4, or 7 days postinjection
or (E) challenged with 10 mg/ml LPS for 3 hr
and then sacrificed 0, 7, or 18 days posttoler-
izing dose injection and adherent cell lysates
from peritoneal lavage fluids pooled and sub-
jected to Western analysis with anti-SHIP.
The blots were reprobed with anti-Shc to
show equal loading. (F) Peritoneal lavage flu-
ids from the three mice sacrificed on days 0,
7, and 18 were assayed individually by ELISA
for TNF	 (left) and IL-6 (right) levels.
of these pathways is the PI3K pathway, and there is a positive role (Hattori et al., 2003; Hirsch et al., 2000;
Li et al., 2003; Madrid et al., 2001; Weinstein et al., 2000),evidence from the literature that PI3K is activated either
by a direct interaction with MyD88 (Ojaniemi et al., 2003) others have shown it has a negative impact (Diaz-Guerra
et al., 1999; Guha and Mackman, 2002; Pahan et al.,or downstream of IRAK (Neumann et al., 2002). In either
case, our results suggest that activation of this pathway 1999; Park et al., 1997). This discrepancy may be due,
in part, to differences in the cell types used and topositively regulates LPS-induced cytokine production
from both BMmφs and BMMCs since we found that the specificity problems with the pharmacological inhibitors
LY294002 and wortmannin (Jung et al., 1999; ShegoguePI3K inhibitors, wortmannin and LY294002, completely
blocked cytokine production and that LPS-induced and Trojanowska, 2004). Interestingly, we found that the
culture conditions used to generate SHIP/ BMmφshigher levels of both intracellular phospho-Stat1 and
TNF	, IL-6, IL-1 in SHIP/ than in SHIP/ BMmφs. had a big impact on the subsequent ability of the mature
SHIP/ BMmφs to generate cytokines in response toHowever, there is substantial controversy concerning
the role of the PI3K pathway in regulating the NFB LPS (while no such effect was observed with SHIP/
progenitors). Specifically, we found that if the SHIP/pathway and subsequent proinflammatory cytokine and
NO production. While some investigators claim it plays progenitors were cultured under low cell density (as
Immunity
236
Figure 7. Model of LPS-Induced Endotoxin
Tolerance
A first dose of LPS activates the PI3K path-
way, which stimulates a number of pathways
including the MyD88/TIRAP/IRAK/TRAF6/
NFB and the TICAM/IRF3/IFN/JAK/Stat1
pathway to trigger the production of proin-
flammatory cytokines and NO (left). Activa-
tion of the second IFN pathway also leads
to the upregulation of the negative regulators
SOCS1. IRAK-M is also increased (middle).
LPS also upregulates the secretion and acti-
vation of TGF, which, in turn, activates the
transcription of the negative regulator SHIP.
A subsequent dose of LPS does not activate
the downstream production of proinflamma-
tory mediators such as NO and TNF	because
of the increased levels of these three negative
regulators (right).
described herein) we always obtained higher levels of tion of autocrine-acting TGF. This is consistent with
previous reports showing that TGF reduces LPS-cytokines in response to LPS than from SHIP/
BMmφs. However, if the SHIP/ macrophage progeni- induced macrophage intracellular signaling (Pender et
al., 1996) as well as NO (Perrella et al., 1996) and TNF	tors were cultured at high cell density, they were far
less capable, once mature, of producing cytokines in production (Randow et al., 1995). Importantly, we now
show that this cytokine induces endotoxin tolerance, atresponse to LPS than wild-type cells. This “priming”
effect may be the result of the production of autocrine- least in part, by upregulating the levels of SHIP in LPS-
stimulated naive macrophages and mast cells (Figureacting negative regulators since we found that SHIP/
BMmφs produce far higher levels of IL-10 in response 7, middle). Interestingly, we found that LPS did not in-
duce a significant increase in the other PI-3,4,5-P3 phos-to LPS than SHIP/ BMmφs (M.J.R. and G.K., unpub-
lished data). Moreover, we found on occasion that the phatases, PTEN, or SHIP2. This is somewhat at odds
with two recent studies, one showing that LPS-treatedlevel of NO produced by SHIP/ BMmφs was lower
than that produced by SHIP/ BMmφs, even when the resting B lymphocytes upregulate both SHIP and SHIP2
(Brauweiler et al., 2001) and another that LPS-treatedSHIP/ progenitors were cultured under low cell den-
sity. This could be because NO levels were measured human peripheral blood monocytes increase SHIP2 lev-
els (Pengal et al., 2003), and may simply reflect cell-typeafter 48 hr, which could allow for various PI3K-induced
negative regulators to inhibit NO production. For exam- differences. Also of interest, even though IRAK-M and
SOCS1 are induced to higher levels in response to LPSple, we have found that both IRAK-M and SOCS1 are
upregulated at the mRNA level by LPS to a higher degree in SHIP/ cells (L.M.S. and G.K., unpublished data),
their induction does not confer endotoxin tolerance inin SHIP/ BMmφs (L.M.S. and G.K., unpublished data),
and this would likely counter some of the positive effects the absence of SHIP. This demonstrates the critical role
that SHIP plays in this phenomenon. Nevertheless, it isof the PI3K pathway on NO production.
As shown in the middle panel of Figure 7 and alluded likely that these three negative regulators act in concert
to downregulate the signaling pathways involved in pro-to above, one of the consequences of exposure to LPS
is the production of a number of autocrine-acting cyto- inflammatory cytokine and NO production since deletion
of either IRAK-M or SOCS1 partially impairs the refracto-kines, including IFN and TGF. IFN, which appears
to be upregulated in response to LPS primarily via a riness to a subsequent LPS exposure (Kinjyo et al., 2002;
Kobayashi et al., 2002; Nakagawa et al., 2002). As well,PI3K-dependent (Weinstein et al., 2000) TICAM/IRF3
pathway (Oshiumi et al., 2003; Yamamoto et al., 2002), a number of other negative regulators either may or
already have been shown to contribute to endotoxintriggers the phosphorylation/dimerization of the tran-
scription factor Stat1 (Imler and Hoffmann, 2003). Phos- tolerance, including the autocrine-acting cytokine IL-10
(Randow et al., 1995) and SOCS3 (Randow et al., 1995).phorylation/dimerization of Stat1, which has also been
shown recently to be PI3K dependent (Rhee et al., 2003), Nonetheless, it appears these efforts at invoking toler-
ance cannot be realized in the absence of SHIP, sug-enables Stat1 to translocate into the nucleus to syner-
gize with NFB in inducing the transcription of both gesting, perhaps, that the elevated PI-3,4,5-P3 levels,
which occur in the absence of SHIP, raise the “thresholdinducible nitric oxide synthase (iNOS) and thus NO pro-
duction, and proinflammatory cytokine genes (Ohmori required for hyporesponsiveness” invoked by IRAK-M,
SOCS-1 and other negative regulators.et al., 1997). As well, as part of a negative feedback
loop, Stat1 also directly upregulates the suppressor of
Experimental Procedurescytokine signaling, SOCS1, and the increased levels of
this inhibitor repress both Stat1 and NFB activation
Antibodies and Reagentsinduced by a second dose of LPS (Crespo et al., 2000;
E. coli LPS from serotype O127:B8 was purchased from Sigma
Kinjyo et al., 2002; Nakagawa et al., 2002). Chemical Company (St. Louis, MO). The PI3K inhibitors LY294002
In this study we demonstrate that LPS induces endo- (LY) and wortmannin (W) were from Calbiochem (La Jolla, CA). The
anti-TLR4 antibody used in flow cytometry was from Torrey Pinestoxin tolerance, in large part, by stimulating the produc-
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Biolabs, Inc. (Houston, TX). Antibodies used in Western blotting 24 hr LPS-tolerized (100 ng/ml LPS) SHIP/ and SHIP/ BMmφs
or BMMCs were incubated 100 ng/ml LPS, and the supernatantsincluded anti-phospho-Akt (Ser473), anti-phospho-NFB p65 (Ser536),
anti-phospho-Erk (Thr202/Tyr204), which were all from Cell Signal- were collected after 3 hr. TGF ELISAs (R & D Systems; Cedarlane;
Hornby, ON, Canada) were carried out with 24 hr serum-free condi-ing Technology (Pickering, ON); anti-SHIP SH2 and C-terminal,
which were described previously (Damen et al., 1998); P1C1 anti- tioned medium. LY294002 (15
M) or wortmannin (50 nM) was added
to naive cells 30 min prior to stimulation. Phosphorothioate-modifiedSHIP (sc-8425, Santa Cruz Biotechnology, Inc., Santa Cruz, CA),
which was used for Odyssey blots; anti-SHIP2, which was gener- oligonucleotides were added as described above. All ELISAs were
performed according to the manufacturers’ instructions.ously provided by Bayard Clarkson from Memorial Sloan-Kettering
Cancer Center (New York, NY); anti-phospho-SHIP, which was gen-
erated in our laboratory against a phosphopepetide corresponding NO Assays
to residues surrounding the phosphorylated Y1020 in human SHIP; SHIP/ and SHIP/ culture supernatants from BMmφs and
anti-PTEN (Santa Cruz); anti phospho-STAT1 (Zymed Laoratories, BMMCs, stimulated as described above, were collected after 48 hr
Inc., San Francisco, CA); anti-GAPDH (Research Diagnostics, Inc., and assessed for nitrite levels by the Griess assay (Kleinbongard et
Flanders, NJ); and anti-Shc (BD Transduction Laboratories, Lexing- al., 2002).
ton, KY). The anti-TGF blocking antibody was from R&D Systems
(Minneapolis, MN). Phosphorothioate-modified oligonucleotides Flow Cytometric Analysis of TLR4 Surface Expression
were synthesized and HPLC purified by Invitrogen (Carlsbad, CA) BMmφs or BMMCs (1 106 cells in 100 
l) were treated100 ng/ml
with the following sequences described previously (Valderrama- LPS for 5 min, 15 min, 1 hr, 2 hr, 4 hr, or 24 hr and stained at 4C
Carvajal et al., 2002); AS1, 5-CAGGGACCATGGCAGGCATG-3; for 30 min with anti-TLR4 (Santa Cruz Biotechnology) followed by
AS2, 5-GGGTGCATTACCCATGTTCC-3; control (S), 5-AGGGGAC FITC-labeled secondary anti-rabbit antibody (Jackson Immuno-
CATGGTGGACGTG-3. Research Laboratories, Inc., West Grove, PA). 10,000 events were
evaluated by flow cytometry.
Production of SHIP/ and SHIP/ BMMCs, BMmφs,
RT-PCRand Peritoneal Macrophages
SHIP/ BMmφs (1  106 cells in 1ml) were treated with 100 ng/mlTo obtain BMMCs, bone marrow cells were aspirated from 4- to
LPS for the indicated times and total RNA prepared by using TRIzol8-week-old C57Bl6  129Sv mixed background mice and SHIP/
(Gibco BRL). Reverse transcription reactions were performed usingand SHIP/ BMMCs prepared as described previously (Huber et al.,
oligo (dT)18 and MMLV reverse transcriptase (Stratagene). PCR reac-1998). After 8 weeks in IMDM  15% FCS (StemCell Technologies,
tions were carried out at 94C for 1 min, 65C for 1 min and 72CVancouver, Canada)  150 
M monothioglycerol (MTG)  30 ng/ml
for 1 min  24 cycles for SHIP and IRAK-M, 27 cycles for SOCS1IL-3 (BMMC medium), more than 99% of the cells were c-kit and
and 16 cycles for -actin. The primer pairs for SHIP were 5- GTGACFcR1 positive as determined by flow cytometry with FITC-labeled
CCACCTGCAGTACC-3 (forward) and 5-ACGATCAGTTTCCCAanti-c-kit (BD Pharmingen, Mississauga, Canada) and FITC-labeled
GACTCA-3 (reverse), for IRAK-M were 5-AGCCAAAGCCATCCAAIgE (anti-Epo 26), respectively.
TACTT-3 (forward) and 5-GTGGGTCTTAACTTGGCCTTC-3 (re-BMmφs from SHIP/ and SHIP/ mice were obtained as de-
verse), for SOCS1 were 5-GAGCTGCTGGAGCACTACG-3 (forward)scribed previously (Bourgin et al., 2002) and maintained in IMDM 
and 5-GAGGTCTCCAGCCAGAAGTG-3 (reverse), and -actin were10% FCS  150 
M MTG  2% C127 cell-conditioned medium as
5-TGGAATCCTGTGGCATCCATGAAAC-3 (forward) and 5-TAAAACa source of macrophage colony-stimulating factor (M-CSF) (BMmφ
GCAGCTCAGTAACAGTCCG-3 (reverse).medium). Specifically, bone marrow cells from each mouse (both
femurs and tibias) were first suspended in 40 ml of IMDM 10%
FCS and allowed to adhere for 3 hr at 37C in a 75 cm2 Nunclon Mouse Model of Endotoxin Tolerance
Six-week-old SHIP/ and SHIP/ mice tolerization with 1 mg/kgflask. The nonadherent cells were then diluted to 60 ml with IMDM
so that they contained final concentrations of 10% FCS  150 
M LPS IP were challenged or not at 24 hr with 10 mg/kg LPS IP. Heart
punctures were performed and blood collected in heparinized tubes.MTG  2% C127 cell-conditioned medium and plated in a 175 cm2
Nunclon flask for 10 days at 37C, with total medium changes of Plasma was isolated by centrifugation at 13,000  g for 10 min.
Peritoneal lavage (3 ml/mouse) was performed and the cells recov-the adherent cells at days 5 and 10.
SHIP/ and SHIP/ peritoneal macrophages were obtained by ered by centrifugation at 300  g for 5 min. Myeloperoxidase (MPO)
assays were performed as previously described (Bradley et al.,lavage of the peritoneal cavity with 3  5 ml of IMDM  10% FCS 
150 
M MTG. The cells were then incubated overnight at 37C in 1982). Lavage supernatants were also used for TNF	 and IL-6
ELISAs.96-well, flat-bottom tissue culture plates and the adherent cells
washed and incubated in the above medium at 1  106 cell/ml.
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